483 GlaxoSmithKline dba Human Genome Sciences Jul 2015

483 GlaxoSmithKline dba Human Genome Sciences Jul 2015

Thuy Nguyen FDA, Michael Shanks FDA$119.00 - Available Now

FDA investigators audited the GlaxoSmithKline dba Human Genome Sciences - Rockville, MD, United States facility and issued inspectional observations (via FDA 483) on 24 Jul 2015.

Product details

  • Category: Human Drugs
  • Inspection end: 24 Jul 2015
  • Location: Rockville, United States
  • FEI: 3003782237
Add To Cart